These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3814927)
21. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Harvey PD; Howanitz E; Parrella M; White L; Davidson M; Mohs RC; Hoblyn J; Davis KL Am J Psychiatry; 1998 Aug; 155(8):1080-6. PubMed ID: 9699697 [TBL] [Abstract][Full Text] [Related]
22. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922 [TBL] [Abstract][Full Text] [Related]
23. Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients. Evans JD; Negron AE; Palmer BW; Paulsen JS; Heaton RK; Jeste DV J Geriatr Psychiatry Neurol; 1999; 12(1):11-5. PubMed ID: 10447149 [TBL] [Abstract][Full Text] [Related]
24. Positive and negative syndromes in schizophrenia as a function of chronicity. Kay SR; Fiszbein A; Lindenmayer JP; Opler LA Acta Psychiatr Scand; 1986 Nov; 74(5):507-18. PubMed ID: 3492863 [TBL] [Abstract][Full Text] [Related]
25. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Dominguez Mde G; Viechtbauer W; Simons CJ; van Os J; Krabbendam L Psychol Bull; 2009 Jan; 135(1):157-71. PubMed ID: 19210058 [TBL] [Abstract][Full Text] [Related]
26. Three syndromes in chronic schizophrenia. Liddle PF; Barnes TR; Morris D; Haque S Br J Psychiatry Suppl; 1989 Nov; (7):119-22. PubMed ID: 2695133 [No Abstract] [Full Text] [Related]
27. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases. Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362 [TBL] [Abstract][Full Text] [Related]
28. Frequency and differential diagnosis of depressive syndromes in schizophrenia. Martin RL; Cloninger CR; Guze SB; Clayton PJ J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255 [TBL] [Abstract][Full Text] [Related]
29. Using discriminant function analysis with clinical, demographic and historical variables to diagnose schizophrenia. Newmark CS; Jones MT; McKee DC; Simpson M; Boren RB; Prillaman K Br J Med Psychol; 1980 Dec; 53(4):365-73. PubMed ID: 7437357 [TBL] [Abstract][Full Text] [Related]
30. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients]. Nkam I; Langlois-Thery S; Dollfus S; Petit M Encephale; 1997; 23(4):267-72. PubMed ID: 9417392 [TBL] [Abstract][Full Text] [Related]
31. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Perlick DA; Rosenheck RA; Kaczynski R; Bingham S; Collins J Schizophr Res; 2008 Feb; 99(1-3):192-9. PubMed ID: 17851042 [TBL] [Abstract][Full Text] [Related]
32. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. Jabben N; Arts B; van Os J; Krabbendam L J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370 [TBL] [Abstract][Full Text] [Related]
33. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter? Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145 [TBL] [Abstract][Full Text] [Related]
34. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia. Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309 [TBL] [Abstract][Full Text] [Related]
35. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables. de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181 [TBL] [Abstract][Full Text] [Related]
36. [Follow-up dynamics of schizophrenic diseases in adolescence]. Schulz E; Martin M; Remschmidt H Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322 [TBL] [Abstract][Full Text] [Related]
37. Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. Verdoux H; van Os J; Sham P; Jones P; Gilvarry K; Murray R Br J Psychiatry; 1996 May; 168(5):620-6. PubMed ID: 8733802 [TBL] [Abstract][Full Text] [Related]
38. Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study. Bulgari V; Iozzino L; Ferrari C; Picchioni M; Candini V; De Francesco A; Maggi P; Segalini B; de Girolamo G; Schizophr Res; 2017 Mar; 181():124-130. PubMed ID: 27765521 [TBL] [Abstract][Full Text] [Related]
39. Positive and negative symptoms. Relation to familial transmission of schizophrenia. Baron M; Gruen RS; Romo-Gruen JM Br J Psychiatry; 1992 Nov; 161():610-4. PubMed ID: 1422608 [TBL] [Abstract][Full Text] [Related]
40. Significance of the positive-negative distinction in schizophrenia. Kay SR Schizophr Bull; 1990; 16(4):635-52. PubMed ID: 2077641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]